IP Library Granted Patent US 9,358,255
Granted Patent B2
US 9,358,255 · App. 14/049,026 · Granted Jun 7, 2016

Methods and devices for obtaining and providing combination cell therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,255
App. No.
14/049,026
Granted
Jun 7, 2016
Kind
B2
Abstract

The invention is directed to a method for isolating stromal cells to form a therapeutic composition; and administering said therapeutic composition to the subject. A further embodiment of the invention is directed to therapeutic compositions comprising isolated stromal cells.

Claims (18)

1. A method for treating a human subject with a combination cell therapy comprising bone marrow derived stromal cells and adipose tissue derived stromal cells, the method comprising:

isolating stromal cells compatible with the subject, the isolating comprising:

aspirating bone marrow from the subject with a heparin-coated needle;

collecting adipose tissue from the subject, the collecting comprising a suction device comprising a first valve adapted to control a pressure within an inner space of the suction device and a second valve adapted to control a pressure in an annular-shaped peripheral suction chamber disposed about the rim of the suction device to aid in sealing the suction device to the subject, and further comprising a recovery cannula;

combining stromal cells isolated from bone marrow with stromal cells isolated from adipose tissue to form a therapeutic composition; and

administering said therapeutic composition to the subject.

2. The method of claim 1 , wherein the stromal cells are isolated from at least two different sources.

3. The method of claim 1 , further comprising the steps of:

obtaining blood compatible with the subject; and

fractionating said blood to produce a blood component, said blood component selected from the group consisting of platelet-poor plasma, concentrated platelet-poor plasma, platelet-rich plasma, and combinations thereof.

4. The method of claim 3 , wherein said blood component is combined with the isolated stromal cells to form a therapeutic composition.

5. The method for treating a human subject according to claim 1 , wherein said stromal cells are isolated from tissue obtained from said subject.

6. The method for treating a human subject according to claim 1 , wherein said stromal cells are washed at least once with a fluid selected from the group consisting of platelet-rich plasma, platelet-poor plasma, concentrated platelet-poor plasma, whole blood, and combinations thereof.

7. The method for treating a human subject according to claim 1 , wherein the isolated stromal cells are able to differentiate into cells selected from the group consisting of chondrocytes, endothelial cells, osteoblasts, myocytes, neural cells, glial cells, adipocytes, pericytes, cardiomyocytes, epithelial cells, fibroblasts, and combinations thereof.

8. The method for treating a human subject according to claim 1 , further comprising administering to the subject an additive selected from the group consisting of a cytokine, bioactive material, scaffold, buffer, or combinations thereof.

9. The method for treating a human subject according to claim 1 , wherein the peripheral rim of the suction device is flat.

10. The method for treating a human subject according to claim 1 , wherein the peripheral rim of the suction device is contoured to provide improved engagement with a portion of the subject that is not flat.

11. The method for treating a human subject according to claim 1 , wherein the peripheral rim of the suction device further comprises an O-ring placed in a track that is adjacent to the annular-shaped peripheral suction chamber.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: AMERICAN BANK
To: SPINESMITH HOLIDNGS, LLC
Reel/Frame 048853/0105 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2019
From: SILICON VALLEY BANK
To: SPINESMITH HOLDINGS, LLC
Reel/Frame 048853/0183 →
SECURITY INTEREST Recorded Apr 9, 2019
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, LP
Reel/Frame 048839/0655 →
SECURITY INTEREST Recorded Dec 14, 2017
From: SPINESMITH HOLDINGS, LLC
To: AMERICAN BANK, N.A.
Reel/Frame 044882/0096 →
SECURITY INTEREST Recorded Mar 22, 2017
From: SPINESMITH HOLDINGS, LLC
To: BLUEARC MEZZANINE PARTNERS I, L.P.
Reel/Frame 042071/0370 →
SECURITY INTEREST Recorded Feb 18, 2015
From: SPINESMITH HOLDINGS, LLC
To: SILICON VALLEY BANK
Reel/Frame 035014/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2014
From: DUNWORTH, KEVIN; KANA, RICHARD J.; SAND, THEODORE; MURPHY, MATTHEW
To: SPINESMITH PARTNERS, L.P.
Reel/Frame 032216/0988 →